Latest Commercialisation News

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Emperor Energy appoints Tim Handley as Managing Director to spearhead the Judith Gas Field's next phase, including the critical Judith-2 appraisal well planned for Q3 2026.

DataWorks Group signals a turning point with its strongest quarterly operating cash flow since refocusing on its core RegTech business, driven by key contracts in Australia and Ontario.

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.

Ore Resources has completed its Phase 3 drilling at the Miriam Project, targeting extensions of high-grade gold lodes, with assay results expected in late January 2026. The company is well-funded and poised for an active exploration program in 2026.

Encounter Resources reports significant extensions of shallow, high-grade niobium mineralisation east of its Green Mineral Resource Estimate at the Aileron Project, with promising drill results and a major development program planned for 2026.

Elixir Energy has partnered with QGC to share 3D seismic data over a key Queensland gas permit, aiming to reduce risks ahead of the Daydream-3 appraisal well. This collaboration highlights the strategic importance of the Taroom Trough in Australia’s gas landscape.

Forrestania Resources has crossed the critical 50% acceptance threshold in its takeover of Kula Gold, signaling strong shareholder backing and advancing its regional consolidation strategy in Western Australia's gold belts.

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.

HyTerra Limited has appointed Riley Kemp as its new CEO, aiming to accelerate growth and strengthen its position in the emerging geologic hydrogen sector.

Radiopharm Theranostics reports promising interim Phase 2b results for RAD 101, achieving 92% concordance with MRI in detecting brain metastases, paving the way for a pivotal study in 2026.